Document is current

Any future updates will be listed below

Erster, oraler BCL-2-Inhibitor bei CLL

Crossref DOI link: https://doi.org/10.1007/s15004-017-5766-9

Published Online: 2017-09-02

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark